昭衍新药

- 603127

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013 
昭衍新药(603127) 利润表
单位:万元
报表日期2022-09-302022-06-302022-03-312021-12-312021-09-30
一、营业总收入127,639.3077,688.1227,097.55151,668.0085,680.44
营业收入127,639.3077,688.1227,097.55151,668.0085,680.44
二、营业总成本81,001.2750,326.8317,851.49108,697.8568,999.39
营业成本64,198.1139,647.1313,091.5577,755.8043,091.11
营业税金及附加729.72551.20226.56869.19639.89
销售费用1,238.99818.45394.671,597.251,161.09
管理费用23,321.7115,322.816,392.2825,615.6219,553.69
财务费用-13,492.65-8,560.99-3,482.49-1,915.581,051.62
研发费用5,005.392,548.231,228.914,775.563,501.99
资产减值损失----------
公允价值变动收益23,576.8313,511.393,835.2415,777.758,006.96
投资收益842.79467.34425.081,700.001,199.52
其中:对联营企业和合营企业的投资收益-163.25-35.05---42.55--
汇兑收益----------
三、营业利润71,777.5642,065.9613,982.5564,288.9228,154.47
加:营业外收入1,463.561,462.110.0041.733.83
减:营业外支出20.6913.286.86130.28128.09
其中:非流动资产处置损失----------
四、利润总额73,220.4343,514.7913,975.6964,200.3728,030.21
减:所得税费用10,123.176,476.361,487.748,558.743,329.26
五、净利润63,097.2637,038.4312,487.9555,641.6324,700.95
归属于母公司所有者的净利润63,203.3237,111.9612,534.7455,745.9624,800.62
少数股东损益-106.06-73.53-46.78-104.33-99.66
六、每股收益
基本每股收益(元/股)1.18000.97000.33001.51000.9500
稀释每股收益(元/股)1.18000.97000.33001.50000.9400
七、其他综合收益3,518.891,808.82-103.15-247.72-144.18
八、综合收益总额66,616.1538,847.2412,384.8055,393.9124,556.77
归属于母公司所有者的综合收益总额66,722.2038,920.7712,431.5955,498.2424,656.43
归属于少数股东的综合收益总额-106.06-73.53-46.78-104.33-99.66
下载全部历史数据到excel中 返回页顶